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Abstract
T CELL INTEGRIN DEPENDENT, MKK3/p38 MAPK-MEDIATED STABILIZATION OF LABILE CYTOKINE
mRNAs.
Scott D. DeGregorio Vinod S. Ramgolam, Sharmila Subaran, Mark Collinge, Hongbo Chi, Richard A. Flavell, and
Jeffrey R. Bender. Section of Vascular Biology and Transplantation, Yale University School of Medicine, New
Haven, CT.

The goal of this project is to elucidate the signaling pathway involved in the T cell integrin lymphocyte functionassociated antigen 1 (LFA-1) engagement-mediated, HuR nuclear-to-cytoplasmic translocation and subsequent mRNA
stabilization.
To examine the pathway transducing LFA-1 engagement-mediated mRNA stabilization, we employed
quantitative, real time RT-PCR in the presence of a transcriptional inhibitor to examine the half-life of interferon gamma
(IFN-γ) mRNA, a labile cytokine transcript.

We used immunofluorescence to observe the nuclear-to-cytoplasmic

tranlocation of HuR, an mRNA-binding and –stabilizing protein. We also used Western blot analysis to analyze the
activity levels of specific mitogen activated protein kinases (MAPKs) upon LFA-1 engagement. These techniques were
performed using murine splenocyte-derived T cells from wild type as well as transgenic mice lacking one or both copies of
the MAPK kinase MKK3 gene. They were also performed in the presence of MAPK pharmacologic inhibitors, RNA
interference for HuR, and transfection vectors for constitutively active Rho-GTPases and MAPKs.
Our data show that, in murine wild type T cells, LFA-1 engagement by its ligand, intercellular adhesion
molecule-1 (ICAM-1), causes both HuR translocation and an increased half-life of IFN-γ mRNA transcripts. This mRNA
stabilization is HuR-dependent: a decrease in HuR expression in T cells by RNA interference abrogates the LFA-1
induced IFN-γ mRNA stabilization.
To examine the pathway responsible for LFA-1 engagement-mediated mRNA stabilization, we looked at
MAPKs since T cell integrin engagement triggers mitogenesis. LFA-1 engagement activates both c-jun NH2 terminal
protein kinase (JNK), and stress activated protein kinase (SAPK) (also known as the p38 MAPK).

Pharmacologic

inhibition of JNK, however, causes no decrease in HuR translocation or IFN-γ mRNA stabilization upon T cell integrin
engagement, while pharmacologic inhibition of p38 MAPK inhibits both events. Interruption of the p38 MAPK pathway by
using T cells lacking the p38 MAPK kinase MKK3 also causes a loss of HuR translocation and subsequent IFN-γ mRNA
stabilization upon LFA-1 engagement. Activation of the p38 MAPK pathway alone via a constitutively active p38 MAPK
kinase MKK6, however, was not sufficient to obtain IFN-γ mRNA stabilization.
From these data, we conclude that T cells utilize LFA-1 engagement by ICAM-1 to modulate the stability of
labile mRNA transcripts encoding proinflammatory cytokines. Modulation of the RNA binding molecule HuR is required
for this mRNA stabilization. Furthermore, the MKK3/p38 MAPK pathway is necessary for LFA-1 engagement-mediated
mRNA stabilization. Activation of the p38 MAPK pathway alone, however, is not sufficient to generate the stabilization of
labile, proinflammatory cytokine transcripts.
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Introduction
Leukocytes are specialized immune cells that continually migrate
throughout the bloodstream, into peripheral tissues and peripheral lymphoid
organs (1). The functions of leukocytes can be divided into those subserving
innate and adaptive immunity.

Innate immunity utilizes granulocytes and

macrophages in a non-adaptive mechanism that provides a first line of defense
against infection. The adaptive immune system, on the other hand, is a delayed,
pathogen-specific response mediated by lymphocytes.

The lymphocyte

population has an enormous range of receptors that recognize various
components of pathogens which are called antigens (2).

Lymphocytes are

divided into B lymphocytes and T lymphocytes based on their receptors as well
as their response to antigens. B lymphocytes have antibodies (produced by the
cells themselves) as their antigen receptor. T lymphocytes, on the other hand,
have a T cell receptor (TCR) that only recognizes peptide antigen bound to a
major histocompatability complex (MHC) molecule on the cell membrane.
Because T cells only recognize antigen bound to MHC proteins expressed
on a cell’s plasma membrane, T cells require adhesive interactions with other
cells for their functional activation.

In the thymus, T cells adhere to thymic

epithelial cells for positive or negative selection where, depending on their
reaction to specific MHC-bound proteins, they will receive mitogenic or apoptotic
signals. Upon entering the peripheral circulation, T cells will adhere to various
antigen presenting cells (APCs) and receive mitogenic or lineage-specific
differentiation signals depending on the environment within which the T cell binds
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to the APC. Once T cells have differentiated, strong adhesion with APCs is a
requirement for activation of T cell effector functions (3).
The T cell receptors for adhesive interactions are integrins, a ubiquitously
expressed, highly conserved family of receptors involved in cell-extracellular
matrix and cell-cell adhesion (1, 3, 4).

Integrins are heterodimeric proteins

consisting of two subunits. The ligands for the β2 subset (leukocyte-specific)
integrin receptors are the intercellular adhesion molecules (ICAMs), a group of
proteins within the immunoglobulin superfamily that are expressed by APCs as
well as vascular endothelium (3, 4).
Specifically, T cells express the αLβ2 intregrin lymphocyte functionassociated antigen 1 (LFA-1), which is composed of the subunits CD11a and
CD18 (1). Within the thymus, LFA-1 appears to be important in the process of T
cell selection. Research suggests that LFA-1 is required for the maturation of
CD8+ T cells (4, 5).

LFA-1 also appears to play an integral role in T cell

mitogenesis. Simultaneous engagement of both the TCR and LFA-1 causes a
more robust cell cycle transition from G1 to S phase than engagement of the
TCR alone (6). In the periphery, LFA-1 appears to play a key role in T cell
differentiation, especially in the differentiation of naïve T cells into TH1 cells.
Inhibition of naïve T cell LFA-1 interaction with ICAM-1 on the dendritic cell
membrane leads to a predominance of TH2 cell development (7). Furthermore,
addition of ICAM-1 to anti-CD3/CD28-stimulated naïve T cells (anti-CD3/CD28 is
used to stimulate the TCR) causes a Th1 phenotype which is blocked by the
addition or anti-ICAM-1 or anti-LFA-1 blocking antibodies (8).
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One of the important effector functions of differentiated T cells is the
production of pro-inflammatory cytokines, which have tightly controlled
expression profiles. LFA-1 engagement in the presence of CD3-activated T cells
causes an amplification of the steady state IFN-γ mRNA levels. Furthermore,
IFN-γ is a labile transcript with a destabilizing AU-rich element (ARE) in its 3’
untranslated region (3’-UTR).

Measurement of IFN-γ mRNA half-life using a

mRNA polymerase II inhibitor reveals a profound stabilization of the transcript
when LFA-1 is engaged in CD3-stimulated T cells (3, 9).

Thus, LFA-1

engagement leads to an increase in IFN-γ mRNA transcripts, as well as
increased stability of those transcripts, within T cells (10).
Another important effector function of differentiated T cells is migration of
T cells across vascular endothelium.

T cell migration is essential to the

pathogenesis of many inflammatory diseases, as well as to the ultimate
localization of cells homing to a particular tissue or site of inflammation.
Endothelial migration requires interaction between the T cell and the endothelial
cell and its underlying basement membrane. The process begins with a process
called rolling, followed by arrest and firm adhesion.

Rolling is mediated by

selectins, while firm adhesion requires the integrins LFA-1 and VLA-4, which bind
ICAM-1 and VCAM-1, respectively, on the endothelial cell (1, 3). Blockade of
ICAM-1, VCAM-1, or both on endothelial cells prevents the formation of
pseudopodia and lamellipodia by leukocytes, which are phenotypic indicators of
cell arrest and are required for transendothelial migration (11).
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To migrate across the endothelium successfully, T cells must be able to
degrade proteins in the basement membrane and extracellular matrix (ECM).
Matrix metalloproteinases (MMPs) are a family of endopeptidases used by T
cells to break down ECM.

T cells constitutively express small quantities of

MMPs, and engagement of the integrin VLA-4 can both increase the expression
of MMPs by T cells as well as increase enzyme activity (12). While MMPs are
vital to T cell migration through the basement membrane and ECM, the
plasminogen activation system plays a crucial role in cell migration into
surrounding tissue. Plasmin is a serine protease that breaks down ECM proteins
outside of the endothelium. It circulates through the body in the inactive, proform plasminogen and is converted to plasmin by urokinase plasminogen
activator (uPA). uPA binding to its receptor, uPAR, is required for its activation.
uPAR is inducibly expressed by T cells. Engagement of LFA-1 or VLA-4 in CD3stimulated T cells potently induces T cell expression of uPAR (13). Like IFN-γ
mRNA, the uPAR transcript contains a destabilizing ARE in its 3’-UTR.
Furthermore, CD3/LFA-1 co-stimulation-induced T cell transmigration across a
matrigel-coated filter is enhanced by the addition of plasminogen and inhibited by
amiloride (uPAR inhibitor) as well as by an antibody that blocks the uPA binding
site on uPAR (3). Thus, induced T cell uPAR is functional to promote migration.
T cell integrin engagement is required for many of the T cell’s most
important functions, such as thymic selection and mitogenesis, T cell
differentiation, cytokine expression, and migration across vascular endothelium
into surrounding tissues. Data suggest that integrin engagement regulates T cell
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post-transcriptional events, which in turn affect T cell function. As previously
mentioned, many of the mRNA transcripts affected by integrin engagement
contain a destabilizing ARE in the transcript’s 3’-UTR. These transcripts include
cyclin A and cyclin B1 (responsible for thymic mitogenesis) in addition to IFN-γ
and uPAR (14).

LFA-1 engagement in CD3-stimulated T cells causes a

stabilization of each of these transcripts. To determine if the ARE in the 3’-UTR
is important to LFA-1-mediated mRNA stabilization, the uPAR 3’-UTR was
cloned into an otherwise stabile rabbit β-globin transcript. When the construct
was expressed in T cells, the 3’-UTR caused a destabilization of the rabbit βglobin transcript, which was reversed by mutagenesis of the uPAR ARE within
the 3’-UTR.

Furthermore, LFA-1 engagement of the T cell containing the

construct conferred stability to the rabbit β-globin transcript (9). These findings
confirm that LFA-1 engagement on T cells generates at least one signal that
inhibits mRNA instability caused by an ARE in the transcript’s 3’-UTR.
One possible candidate for the mRNA stabilization signal signal generated
by LFA-1 engagement is the molecule HuR. HuR, which is a member of the
embryonic lethal, abnormal vision (ELAV) family of proteins, has been shown to
bind AREs within the 3’-UTR of mRNA transcripts and have a stabilizing effect on
these transcripts (15, 16). In a resting T cell, HuR resides in the nucleus. LFA-1
engagement causes a nuclear-to-cytoplasmic translocation of HuR, which is
required for stabilization of mRNA transcripts containing AREs (9, 17, 18). This
mRNA stabilization facilitates enhanced expression of critical T cell gene
products in response to integrin engagement.
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The molecular signaling pathway responsible for transducing the signal
between LFA-1 engagement and HuR nuclear-to-cytoplasmic translocation is
unknown. Previous work done in the lab demonstrates that LFA-1 activates Vav1 in a PI-3 Kinase dependent manner. Vav-1 is a guanine nucleotide exchange
factor (GEF) for Rac-1 and Rac-2.

Rac-1 and Rac-2 are Rho-GTPases,

implicated in MAPK signaling in T cells, which exist in a non-active, GDP-bound
state. Activation of Vav-1 causes Rac to exchange its GDP for GTP, activating
Rac and thus its downstream effectors.

Both Vav and Rac activation are

required for LFA-1-mediated mRNA stabilization

(Ramgolam

et

al,

in

preparation). The pathway distal to Rac-1/Rac-2 activation, however, remains
unknown.

Since two of the proteins stabilized by LFA-1 engagement are

responsible for mitogenesis within T cells, the most likely candidates for the
signaling pathway include the mitogen-activated protein kinases (MAPKs). In T
cells, there are three major MAPK pathways: the extracellular signal regulated
protein kinase (ERK) pathway, the c-jun NH2 terminal protein kinase (JNK)
pathway, and the stress activated protein kinase (SAPK) pathway (also known as
the p38 MAPK pathway) (19). Of these three pathways, the JNK pathway and
the p38 MAPK pathway are the most likely candidates. In the thymus, the MAPK
kinase MKK6, which activates p38 MAPK, is responsible for T cell selection.
Specifically, it is responsible for the deletion of CD4+CD8+ T cells within the
thymus (20).

The JNK and p38 pathways are both integral in T cell

differentiation. Activation of p38 in naïve T cells causes the release of IL-12,
while both p38 and the JNK isoform JNK2 stimulate differentiation of naïve T
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cells into Th1 cells (21, 22). Furthermore, JNK1 inhibits Th2 differentiation of
naïve T cells, promoting a Th1 phenotype (23). Thus, the JNK and p38 MAPK
pathways both promote Th1 differentiation of naïve T cells, which induces the
expression of IFN-γ and TNF-α, two cytokines whose mRNA transcripts contain
AREs in their 3’-UTRs.
There is also evidence linking the p38 MAPK pathway to HuR nuclear-tocytoplasm translocation and mRNA stabilization directly (24, 25). These findings
were confirmed in a paper by Han et al which established that the Rac1/MKK3/p38MAPK/MK2

pathway

is

involved

in

ARE-mediated

mRNA

stabilization in breast cancer cells (26). This study is important because it not
only confirms the possible role of p38 MAPK in HuR-mediated mRNA
stabilization, it also established the Rho-GTPase Rac-1 as being upstream of
p38 MAPK, as well as MAPK-activated protein kinase 2 (MK2) as being a
downstream effector of p38. MKK3, which is directly downstream of Rac-1 in this
study, is the MAPK kinase that activates p38 MAPK within T cells outside of the
thymus (27). Another study linked MK2 to HuR mediated mRNA stabilization of
uPAR transcripts, providing indirect evidence that LFA-1 engagement may
mediate HuR translocation and subsequent mRNA stabilization through the p38
MAPK pathway (17). However, no study up to this point has directly investigated
and defined the intermediaries between LFA-1 and HuR.
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Statement of Purpose
The goal of this project is to elucidate the signaling pathway involved in T
cell LFA-1 engagement-mediated HuR nuclear-to-cytoplasmic translocation and
subsequent mRNA stabilization. We hypothesize that the p38 MAPK pathway,
acting through Rac and MKK3, is the pathway linking LFA-1 with HuR
translocation and Th1 cell effector function.

Methods
(All work was performed by Scott D. DeGregorio unless stated otherwise).
Antibodies and Reagents
The following antibodies (Ab) were used: anti-p38MAPK, phosphop38MAPK, JNK Abs were purchased from Cell Signaling (Beverly, MA), antiphospho-c-Jun, anti-GFP mouse mAbs were purchased from Santa Cruz (CA).
Anti-HuR (3A2) mouse monoclonal Ab was a kind gift from Dr. Joan Steitz (Yale
University, New Haven, CT). Murine anti-CD3 FITC conjugated Abs and NK1.1
PE were purchased from BD Biosciences (San Jose, CA). Phorbol Myristate
Acetate (PMA), poly-L-lysine, 5.6-dichlorobenzimidazole (DRB), and DAPI were
purchased from Sigma (St. Louis, MO).

The pharmacological inhibitors

SB203580 and SP600125 were purchased from Calbiochem (San Diego, CA).
The murine soluble ICAM-1 producing cell line, NS-1, was a generous gift from
Dr. F. Takei (University of British Columbia, Vancouver, Canada) and murine
soluble ICAM-1 was purified as described (Welder et al. 1993). The anti-murine
ICAM-1 mAb YN1/1.74 has been described (Takei et al. 1985).
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Cell preparation, Cell culture, and Transient Transfection
C57BL/6 mice were purchased from Jackson Laboratory (Bar Harbor,
ME). MKK3-/- deficient mice were a gift from Dr. R. Flavell and have been
described before (28). Murine spleens were harvested from wild type C57BL/6,
C57BL/6-backcrossed MKK3+/-, or C57BL/6-backcrossed MKK3-/- mice. Murine
splenic T cells were isolated by negative selection as described before (29).
Briefly, murine spleens were homogenized, centrifuged, and the supernatant
discarded. The cell pellet was rinsed with sterile water to lyse red blood cells.
The cells then passed over a nylon wool column to remove B cells and
macrophages. NK cells were removed using anti-NK1.1 antibodies conjugated to
magnetic beads.

T cells were then stained with murine anti-CD3 FITC-

conjugated Abs and anti-NK1.1 PE-conjugated Abs, of which greater than 95%
were CD3+ positive (Figure 1). Jurkat cells were obtained from the American
Type Culture Collection and maintained in RPMI-1640 medium (Gibco, Grand
Island, NY) supplemented with 10% fetal bovine serum, 2 mM glutamine, and
100 U/ml each of penicillin G and streptomycin.

Plasmids and siRNA sequence
The Rac-2 wild type and constitutively active Rac-2 constructs were a gift
from Dr. Honghbo Chi (Yale University, CT, USA). The pGEF-BOS-CAT and
pBBB-3’UPAR were cloned in our laboratory, by Vinod Ramgolam, as previously
described (9). The constitutively active MKK62E constuct was a generous gift
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from Dr. Holtmann (Medical School of Hanover, Germany). Jurkat cells were
transfected by electroporation. Briefly, cells were washed twice with Optimem
(Invitrogen) and resuspended in Optimem at a concentration of 50 x 106 cells/ml.
Approximately, 20 x 106 cells (400 μl) were transferred in a 0.4 cm
electroporation cuvette (Bio-Rad, CA) with 25 μg of each pDNA (total 75 μg of
pDNA/20 x 106 cells).

Transfections were conducted at 960 μF/250V (Gene

Pulser, Bio-Rad, CA). Cells were cultured overnight in 10 ml media containing
0.5% FBS and 2 mM L-glutamine. Transfection was confirmed by SDS-PAGE of
lysates from transfected cells, or by exogenous mRNA expression by quantitative
real-time PCR.
HuR siRNA primers were designed by Mark Collinge and synthesized by
the Keck Biotechnology resource facility at Yale. The duplex used to specifically
target HuR was: AAGAGUGAAGGAGUUGAAAU, (HuRsiRNA) corresponding to
nucleotides 1187-1205 of human HuR mRNA and is located in the 3’UTR: The
scrambled siRNA sequence was AGCCAAUUCAUCAGCAAUGG (SCsiRNA).
The control duplex was a scrambled version of HuRsiRNA. The duplexes
HuRsiRNA and SCsiRNA were prepared by Qiagen (Valencia, CA).

Immunofluorescence
Glass coverslips were coated with 2.5 μg/ml murine sICAM-1 in PBS or 20
μg/ml poly-L-lysine at 4oC with in H2O overnight at 4oC. Cells were pre-adhered
to poly-L-lysine coated cover slips.

LFA-1 conformational activation was

achieved by treatment with LFA-1 activation buffer (100 mM Tris.HCl, pH 7.5,
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0.9% NaCl, 2 mM MnCl2, 2 mM MgCl, D-glucose 5mM 1.5% BSA). Mn2+ binds to
the metal ion-dependent adhesion site (MIDAS) on the LFA-1α chain and
promotes an allosteric transition to a high affinity state for its ligand(s), thereby
inducing cell adhesion without cell activation. Cells were plated for 60 minutes
on ICAM-1-coated cover slips or cells pre-adhered to poly-L-lysine were also
treated with LFA-1 activation buffer for 60 minutes. Cells were fixed with 4%
paraformaldehyde and permeabilized with 0.1% Triton X-100.

Cells were

blocked with 5% goat serum overnight at 4oC, followed by staining with 5 μg/ml
anti-HuR overnight at 4oC, followed by cyanine 3-conjugated goat anti-mouse
antibody (dilution 1:1000) immunostaining. Cells were co-stained with 0.005%
DAPI for nuclear definition.

p38MAPK and c-Jun phosphorylation (Performed by Vinod Ramgolam,
analyzed by Scott DeGregorio)
Murine T cells (107cells/ml), treated with LFA-1 activation buffer, were preadhered to poly-L-lysine-coated dishes or plated on 2.5 μg/ml sICAM-1 coated
dishes for the indicated time points.

Freshly isolated murine T cells were

stimulated as described above, then lysed with 20 mM Tris.HCl, pH 7.5, 150 mM
NaCl, 5 mM EDTA, 5mM Na4P2O7, 1 mM Na3VO4, 20 mM NaH2PO4, 3mM βglycerophosphate, 10mM NaF. Jurkat Cells were transfected as described above
and stimulated with 10% serum for 4 hrs. p38MAPK and c-Jun phosphorylation
was analyzed by SDS-PAGE and immunoblotted with anti-phospho-p38MAPK,
anti-p38MAPK, phospho-c-Jun and JNK abs and probed with a secondary goat
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anti- mouse or rabbit IRDye conjugated, species-specific antibody (Rockland,
Gilbertsville, PA) and visualized using an Odyssey Imaging Systems (LI-COR,
Lincoln, NE).

mRNA stabilization experiments and Quantitative Real Time-PCR
Petri dishes were coated with either 2.5 μg/ml murine ICAM-1 in PBS or
20 μg/ml poly-L-lysine in H2O overnight at 4oC. Murine T cells (107/sample),
stimulated with 2 ηg/ml phorbol 12-myristate 12-acetate (PMA), were preadhered to poly-L-lysine-coated dishes, or plated on ICAM-1-coated dishes. In
the case of JNK inhibition with SP600125, murine T cells were pre-treated for 60
minutes before stimulation with 2 ηg/ml PMA. mRNA synthesis was inhibited
after 3 hrs of incubation by the addition of 1.0 µM of the RNA polymerase IIspecific inhibitor 5,6-dichloro-1-β-D-ribobenzimidazole (DRB), after which cells
were lysed for RNA isolation. Transfected Jurkat cells were serum-stimulated for
4 hours to allow for rabbit β-globin gene transcription with 10% serum, after
which cell samples were collected every hour up to 4 hours. In the case of
p38MAPK or c-Jun phosphorylation inhibition, cells were treated with 1 μM
SB203850 and 10 μM SP600125, respectively.

RNA was isolated with the

Qiagen RNeasy kit (Qiagen, Valencia, CA). cDNA was prepared from 1 μg of
RNA with iScript (Bio-Rad, CA) and analyzed by quantitative real-time RT-PCR
using the Opticon 2 System (MJ Research, Waltham, MA). SYBR Green PCR kit
was purchased from Qiagen (Valencia, CA). Murine IFN-γ mRNA levels were
normalized against Cyclophilin-α, with expression relative to time 0 when
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transcription was inhibited. The sequence of the primers used were as followed:
Cyclophilin-α Forward primers: ATTATTCCAGGATTCATGTGCCAG, Cyclophilinα Reverse primers: TGAAGGGGAATGAGGAAAATATGG; IFN-γ Forward
primers:

AGCGGCTGACTGAACTCAGATTGTAG;

IFN-γ

Reverse

primers:

GTCACAGTTTTCAGCTGTATAGGG. Rabbit β-globin mRNA were normalized
against CAT, with expression relative to time 0. The sequence of the primers
were as follows:

CAT Forward primers: GGATAGTTTCACCCTTGTT; CAT

Reverse primers: GATTGGCTGAGACGAAAAAC; Rabbit β-globin Forward
primers: TGGTTGTCTACCCATGGACC; Rabbit β-globin Reverse primers:
ATCCACGTGCAGCTTGTCAC.

All primers were synthesized by the Keck

Biotechnology resource facility at Yale.

Results
LFA-1 induces mRNA stabilization
T cell LFA-1 engagement is partially responsible for effector T cell
function, including pro-inflammatory cytokine production. Previous studies that
examined LFA-1 engagement-mediated mRNA stabilization used LFA-1
activating antibodies rather than its natural ligand, ICAM-1. Our first goal was to
show that LFA-1 engagement by ICAM-1 leads to stabilization of mRNA
transcripts.

Murine T cells were stimulated with the phorbol ester PMA

(replacing CD3 engagement as the T cell gene activator) or PMA with ICAM.
After 3 hours of stimulation, transcription was arrested. To assess the half life of
the T cell transcripts present at the time of transcriptional arrest, cells were lysed
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at 0, 15, 30, and 45 minutes after arrest. mRNA levels were evaluated at each
time point by real time RT-PCR. The transcript level for the pro-inflammatory
cytokine IFN-γ was compared to the stable, housekeeping mRNA encoding
cyclophilin-α, at each time point. The results are illustrated in Figure 2. When
cells are stimulated with PMA alone, less than 10% of the IFN-γ transcript is
present in the cell 45 minutes after transcriptional arrest. However, when T cell
β2 integrin is engaged in addition to PMA recruitment, 60% of the IFN-γ transcript
remains at 45 minutes after transcriptional arrest. These results suggest that
LFA-1 engagement by ICAM-1 leads to stabilization of the mRNA transcript
encoding the pro-inflammatory/immune cytokine IFN-γ.

LFA-1 engagement induces HuR nuclear-to-cytoplasmic translocation
IFN-γ mRNA transcripts contain destabilizing AREs in their 3’-UTRs.
Since HuR is known to bind mRNA AREs and prevent degradation of those
transcripts, and since LFA-1 engagement confers stability to IFN-γ transcripts,
we hypothesize that LFA-1 stabilizes the IFN-γ transcripts through HuR. While it
has been demonstrated in human T cells that LFA-1 engagement causes HuR
nuclear-to-cytoplasmic translocation and subsequent mRNA binding, no one has
ever shown a link between LFA-1 engagement and HuR translocation in the
murine system.

Therefore, we attempted to show that LFA-1 engagement

causes HuR translocation in murine T cells. T cells were plated on cover slips
and treated with LFA-1 activation buffer alone, or LFA-1 activation buffer in the
presence of ICAM-1, for up to one hour. The LFA-1 activation buffer contains
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MnCl2 which induces a conformational change in LFA-1, allowing it to bind ICAM1 more avidly. HuR was stained with a fluorescent antibody and compared to
DAPI, a fluorescent marker which stains the nucleus. Each population of cells
were stimulated for 15, 30, 45, and 60 minutes, then washed and fixed to a slide.
In T cells stimulated with ICAM, HuR begins to translocate out of the nucleus as
soon as 15 minutes after incubation with ICAM begins.

After 60 minutes of

adhesion onto ICAM, all visible HuR has translocated out of the nucleus and into
the T cell cytoplasm (Figure 3). Incubation up to 60 minutes with the LFA-1
activation buffer alone does not induce translocation of HuR (data not shown).
We conclude that, in murine T cells, LFA-1 engagement causes HuR nuclear-tocytoplasmic translocation, where it binds to and stabilizes IFN-γ transcripts.

HuR is required for Rac-mediated mRNA stabilization
We have shown that LFA-1 engagement causes both HuR
translocation and mRNA stabilization. Our next goal was to demonstrate directly
that HuR is required for LFA-1-mediated mRNA stabilization. Previous work in
our lab demonstrates the role of the Rho-GTPases Rac-1 and Rac-2 in LFA-1
engagement-mediated mRNA stabilization (Ramgolam et al, in preparation). To
address whether HuR is required for mRNA stabilization, HuR was “knocked
down” via RNA interference in the presence of constitutively active Rac-1 and
Rac-2 constructs.

RNA interference uses small (~21 nucleotide), double-

stranded RNA sequences, complementary to the transcript of interest, which bind
to and cause the degradation of that particular mRNA. RNA interference is much
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more precise than antisense RNA (30). After RNA interference of HuR, mRNA
stabilization was assessed in the presence of constitutively active Rac constructs
which are capable of inducing mRNA stabilization (Ramgolam et al, in
preparation). Unfortunately, due to the inherent inefficiency of T cell transfection,
endogenous IFN-γ mRNA transcripts could not be quantitated to examine
whether constitutive Rac/p38 activation causes mRNA stabilization. Instead, we
co-transfected an mRNA reporter construct as a readout for stabilization.
The exogenous gene used for mRNA stabilization experiments is the
rabbit β-globin gene attached to a serum-inducible promoter. The rabbit β-globin
gene encodes an extremely stable transcript: transfection into human Jurkat T
cells followed by serum-induced transcription generates transcripts that show no
degradation 400 minutes after transcription. The rabbit β-globin gene becomes
destabilized by fusing AREs into its 3’-UTR. By exchanging the natural 3’-UTR of
rabbit β-globin with the 3’-UTR of uPAR, the transcript degrades and is
undetectable 400 minutes after transcription in Jurkat T cells (9).

Since

stabilization of this destabilized rabbit β-globin transcript would presumably
require HuR to bind the AREs and stabilize the transcript, this construct makes
an ideal exogenous vector to analyze HuR-mediated mRNA stabilization.
We transfected Jurkat T cells with the rabbit β-globin construct containing
the uPAR 3’-UTR, as well as a serum-inducible chloramphenicol acyltransferase
(CAT) gene which encodes the stable CAT mRNA and is used to normalize the
transfection efficiency as well a mRNA half life. Cells were then transfected with
either a constitutively active Rac-1 or a constitutively active Rac-2 construct, both
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of which have been shown to induce mRNA stabilization of rabbit β-globin
transcripts containing the uPAR AREs (Ramgolam et al. in preparation). Each
population of cells then received either a 21 nucleotide RNA duplex
complementary to HuR (HuR siRNA), or a scrambled sequence of the HuR
siRNA (scRNA). The results are shown in Figure 4.

Both the constitutively

active Rac-1 and Rac-2 constructs induced mRNA stabilization of the
destabilized β-globin construct in the presence of the scrambled RNA duplex.
When HuR was knocked down by at least 80% of its original level, neither
constitutively active Rac-1 nor Rac-2 were able to induce mRNA stabilization of
the modified β-globin construct. These results show that HuR is required for
Rac-mediated mRNA stabilization. Since Rac-1 and Rac-2 are downstream of
LFA-1, this suggests that HuR is required for LFA-1 engagement-mediated
mRNA stabilization.

LFA-1 engagement activates both the p38 MAPK and JNK pathway
After demonstrating, within a murine system, that LFA-1 engagement
results in HuR translocation and mRNA stabilization of transcripts encoding proinflammatory cytokines, we sought to elucidate the molecules mediating this
signal transduction pathway. As stated in the introduction, the two most likely
effector pathways are the p38 MAPK pathway and the JNK pathway. Cells were
stimulated with ICAM-1 in the presence of LFA-1 activation buffer.

After

stimulation, the cells were lysed and the activity of p38 MAPK and JNK were
quantitated using monoclonal antibodies (it is convention to quantitate p38
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activity with antibodies against phosphorylated p38 MAPK, while quantitating
JNK activity with antibodies against phosphorylated c-jun, the active form of the
JNK substrate). After incubation of murine T cells with ICAM, p38 MAPK and
JNK activity increased twelve-fold and 6.5-fold, respectively, when normalized to
the total level of the respective proteins (Figure 5). These results suggest that
LFA-1 engagement activates both the p38 MAPK pathway and the JNK pathway.

The JNK pathway does not play a role in LFA-1 mediated mRNA
stabilization
Since LFA-1 engagement activates both the p38 MAPK and JNK
pathways, it is possible that p38 MAPK, JNK, both, or neither mediate HuR
translocation and subsequent mRNA stabilization. To analyze whether JNK is
necessary for LFA-1 mediated mRNA stabilization, we used the JNK-specific
pharmacologic inhibitor SP600125 (31). SP600125 competitively blocks the ATP
binding site on JNK, inhibiting JNK’s ability to phosphorylate c-jun.

Using a

concentration of 10 μM SP600125, we were able to inhibit JNK activity without
inhibiting other MAP kinases, such as p38 MAPK (Figure 6a, data not shown).
We then examined the effect of JNK inhibition on mRNA levels in T cells upon
LFA-1 engagement. Cells were stimulated with PMA, PMA and ICAM, or PMA
and ICAM in the presence of SP600125. After stimulation, the cells were lysed
and their mRNA quantitated (Figure 6B). T cells stimulated with PMA and ICAM
demonstrated a twelve-fold increase in IFN-γ mRNA levels when compared to
PMA stimulation alone. The addition of 10 μM SP600125 to the T cells prior to
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PMA and ICAM stimulation did not significantly alter mRNA levels; these T cells
exhibited a 10-fold increase in IFN-γ mRNA levels compared to PMA stimulation.
Since the major role of ICAM-1 stimulated LFA-1 engagement is to stabilize labile
transcripts in this system, these results suggest that JNK is not required in LFA-1
mediated modulation of mRNA levels. However, this does not separate the LFA1 effect on transcriptional vs. post-transcriptional modulation of mRNA levels. To
distinguish

this,

we

PMA/ICAM/SP600125.

stimulated

T

cells

with

PMA,

PMA/ICAM,

and

After stimulation, we arrested transcription and

quantitated IFN-γ mRNA levels at various timepoints folowing transcriptional
arrest. The addition of SP600125 did not abrogate the LFA-1 mediated mRNA
stabilization 60 minutes after transcriptional arrest (Figure 6C). These results
support that JNK is not required for LFA-1 mediated mRNA stabilization.

The JNK pathway does not play a role in LFA-1 mediated HuR translocation
Although JNK is not required for T cell integrin engagement-mediated
mRNA stabilization, it is conceivable that JNK causes HuR translocation
independent of HuR-mediated mRNA stabilization (and raising the possibility that
LFA-1 mediated mRNA stabilization can also occur independently of HuR). To
examine this possibility, we observed HuR translocation in T cells in the
presence of SP600125. Stimulation of T cells with LFA-1 activation buffer and
ICAM in the presence of 10 μM SP600125 has no effect on HuR translocation
(Figure 7). Indeed, doubling the dose of SP600125 to 20 μM did not abrogate
the HuR translocation caused by LFA-1 engagement. After 1 hour of stimulation,
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all visible HuR is in the cytoplasm in the presence of the JNK inhibitor.
Therefore, JNK appears to be required for neither LFA-1 mediated mRNA
stabilization nor LFA-1 mediated HuR translocation.

p38 MAPK is required for LFA-1 mediated mRNA stabilization
After establishing that JNK is not involved in LFA-1 mediated HuR
translocation and subsequent mRNA stabilization, we examined whether p38
MAPK is involved using the p38-specific pharmacologic inhibitor SB203580 (32).
Like SP600125, SB203580 competitively blocks the ATP binding site of p38
MAPK, inhibiting the enzyme’s ability to phosphorylate its substrates.

A

concentration of 1 μM of SB203580 reduced p38 MAPK activity to baseline levels
without inhibiting other MAP kinases (Figure 8A, data not shown). We analyzed
the effect of inhibiting p38 MAPK on LFA-1 modulation of mRNA levels. As in
previous experiments, stimulation with PMA and ICAM causes a twelve-fold
increase in IFN-γ levels when compared to PMA stimulation alone. Stimulating T
cells in the presence of 1 μM SB203580, however, reduces IFN-γ levels to their
baseline value (Figure 8B). This demonstrates that p38 MAPK is required for
LFA-1 mediated modulation of IFN-γ mRNA levels.
As previously stated, the experiment does not separate transcriptional and
post-transcriptional events. To examine whether p38 MAPK is required for LFA1 mediated mRNA stabilization, T cells were transcriptionally arrested after
stimulation with PMA and ICAM in the presence of SB203580. Quantitation of
IFN-γ mRNA levels after transcriptional arrest shows that the addition of the p38
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MAPK inhibitor causes a loss of mRNA stabilization upon LFA-1 engagement by
ICAM.

Interestingly, IFN-γ mRNA levels in T cells stimulated with

PMA/ICAM/SB203580 drop below those in T cells stimulated with PMA alone
(this result is evident in repeated experiments, although statistical significance
was not reached). Together, these data demonstrate that p38 MAPK is required
for LFA-1 engagement-mediated mRNA stabilization.

MKK3 gene-deleted T cells demonstrate loss of p38 MAPK activity
We have pharmacologic evidence that the p38 MAPK pathway is required
for LFA-1 engagement mediated mRNA stabilization. Pharmacologic models are
imprecise, however, given the inherent lack of specificity of pharmacologic
inhibitors. We therefore investigated the p38 MAPK pathway in a more precise,
gene-deleted mouse system. We received MKK3 gene deleted mice as a kind
gift from Dr. Richard Flavell.

(as stated, MKK3 is the MAPK kinase which

activates p38 MAPK in peripheral T cells (27).

Phenotypically, these mice

appear normal, albeit smaller in overall size and with smaller spleens than their
C57BL/6 wild type counterparts.

We bred MKK3 knockout (MKK3-/-) mice

(backcrossed into the C57BL/6 strain) with wild type (MKK3+/+) C57BL/6 mice to
generate heterozygous MKK3 (MKK3+/-) mice.
To confirm that the MKK3-/- mice actually have a deficiency in the p38
MAPK signaling pathway, we isolated T cells from MKK3+/+, MKK3+/-, and MKK3-/mice.

We activated the T cells with LFA-1 activation buffer and ICAM and

analyzed p38 MAPK activity by Western blot. Each population of T cells also had
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an unstimulated control group against which p38 MAPK activity was normalized
(Figure 9A). The MKK3+/- had a 50% reduction in p38 MAPK activity upon LFA-1
engagement when compared to MKK3+/+ T cells, and the MKK3-/- cells had a
75% reduction in p38 MAPK activity when compared to the wild type cells. In
contrast, upon LFA-1 engagement, there is no correlation between JNK activity
and the number of wild-type MKK3 alleles in T cells (Figure 9B). These results
indicate that MKK3 gene-deleted mice do have a selective defect p38 MAPK
pathway, with other MAPK signaling pathways intact.

MKK3-/- T cells have reduced IFN-γ mRNA levels upon LFA-1 engagement
Since pharmacologically inhibiting p38 MAPK causes a decrease in IFN-γ
mRNA levels upon LFA-1 engagement, we hypothesized that knocking out MKK3
would also cause a reduction in IFN-γ levels upon T cell integrin engagement,
although it is possible that multiple upstream kinases can co-activate p38 upon
LFA-1 engagement. There are at least 2 known MAPK kinases that activate p38
MAPK (MKK3 and MKK6), and it is possible that MKK6, or some other currently
unknown MAPK kinase, activates p38 MAPK and causes the HuR translocation
and subsequent mRNA stabilization independent of MKK3. To examine whether
MKK3 is, in fact, the MAPK kinase responsible for LFA-1 mediated mRNA
stabilization via p38 MAPK, we isolated MKK3+/+, MKK3+/-, and MKK3-/- T cells
and analyzed IFN-γ mRNA levels upon integrin engagement. After stimulation
with PMA and ICAM, MKK3+/- T cells contained 50% less IFN-γ mRNA than wild
type T cells, while MKK3-/- T cells express 80% less IFN-γ than wild type T cells
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(Figure 10).

These results suggest that MKK3 is required for IFN-γ mRNA

modulation upon T cell integrin engagement.

MKK3 KO T cells exhibit a loss of LFA-1 mediated mRNA stabilization
As stated previously, the prior experiment does not separate transcription
vs. post-transcriptional modulation of mRNA levels. To examine whether loss of
the MKK3 gene causes instability of mRNA, T cells were stimulated as in
previous experiments, mRNA transcription arrested, and IFN-γ mRNA levels
quantitated at various timepoints after transcriptional arrest (Figure 11).

As

expected, in MKK3+/+ mice, stimulation with PMA and ICAM increases the half life
of IFN-γ mRNA levels, with 80% of transcripts present 45 minutes after
transcriptional arrest.

If the MKK3 gene is completely knocked out, T cells

largely lose the mRNA stabilization conferred by LFA-1 engagement: mRNA
levels are 30% of their original value 45 minutes after transcriptional arrest.
Surprisingly, the T cells with only one copy of the MKK3 gene exhibit complete
stabilization of IFN-γ mRNA transcripts when compared to wild type T cells,
despite reduced p38 MAPK activity compared to wild type T cells. These results
suggest that MKK3 is required for LFA-1 mediated mRNA stabilization through
p38 MAPK.

Furthermore, MKK3 appears to act in a threshold-dependent

manner rather than a dose-dependent manner for its mRNA stabilization
phenotype.
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MKK3 KO T cells exhibit a loss of LFA-1 mediated HuR nuclear-tocytoplasmic translocation
Since MKK3-/- T cells demonstrate a loss of T cell integrin-mediated mRNA
stabilization, we hypothesized that loss of MKK3 in T cells may also cause a loss
of LFA-1 mediated HuR nuclear-to-cytoplasmic translocation.

We isolated

MKK3+/+, MKK3+/-, and MKK3-/- T cells and stimulated them with ICAM in the
presence of LFA-1 activation buffer. LFA-1 activation buffer alone caused no
HuR translocation in any of the three populations of T cells (data not shown).
While stimulating wild type T cells with ICAM causes complete HuR
translocation, stimulation of MKK3-/- T cells with ICAM causes no visible
movement of HuR from the nucleus into the cytoplasm (Figure 12).

This

confirms our suspicion that MKK3 is required for LFA-1 mediated HuR
translocation and subsequent mRNA stabilization. Furthermore, in MKK3+/- T
cells, ICAM stimulation causes complete HuR translocation from the nucleus to
the cytoplasm.

This mirrors the finding in the previous experiment that the

MKK3+/- T cells phenotypically behave identically to MKK3+/+ T cells with respect
to HuR translocation and subsequent mRNA stabilization despite having reduced
p38 MAPK activity levels.

Discussion
Our results support the hypothesis that the p38 MAPK pathway, acting
through Rac-1/Rac-2 and the MAPK kinase MKK3, plays an integral role in
peripheral T cell integrin engagement-mediated HuR translocation and
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subsequent mRNA stabilization.

The pathway we propose from our data is

illustrated in Figure 13. Previous work in our laboratory demonstrates that LFA-1
activation leads to Rac-1 and Rac-2 activation (Ramgolam et al., in preparation).
The Rac proteins activate JNK, via MKK4 and MKK7, as well as p38 MAPK
through MKK3 and MKK6. JNK has been implicated in T cell differentiation (23)
and, per our results, does not play a role in LFA-1 mediated mRNA stabilization.
MKK3, acting through p38 MAPK, is required for T cell integrin-mediated mRNA
stabilization.

Activation of p38 MAPK alone through MKK6, however, is not

sufficient to induce mRNA stabilization (data not shown). These data suggest
that p38 is necessary but not sufficient for LFA-1 mediated mRNA stabilization.
Therefore, signaling protein(s) separate from p38 MAPK must be involved in
LFA-1 engagement-mediated mRNA stabilization. These proteins have to be
activated at or above the level of MKK3 within the signaling cascade.

One

candidate class of proteins that may be involved in LFA-1 mediated mRNA
stabilization is cytoskeletal proteins. Integrin engagement on T cells causes a
shift in proteins within the immunologic synapse that is cytoskeleton-dependent
(33).

In addition, observation of T cells, upon LFA-1 engagement by ICAM,

reveals striking morphologic changes by the T cell, whereupon it spreads along
the ICAM and develops numerous lamellopodia.

Furthermore, experiments

studying LFA-1 engagement in the presence of cytochalasin D, a pharmacologic
inhibitor of actin polymerization, show that T cells require cytoskeletal
rearrangement for MAP kinase activation (3), mitogenesis (34), and mRNA
stabilization (Ramgolam, unpublished data) upon integrin engagement. While
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our lab has shown a loss of T cell integrin-mediated mRNA stabilization upon
inhibition of actin polymerization, a loss of HuR translocation upon actin
polymerization has not been evaluated. However, in natural killer cells, LFA-1
engagement was found to cause Vav-1 phosphorylation, which in turn was
upstream of subsequent cytoskeletal reorganization (35). Thus, it is possible that
in T cells, Vav, Rac, and/or MKK3 induce cytoskeletal rearrangement in addition
to p38 MAPK activation, and that both p38 MAPK activity and cytoskeletal
rearrangement are required for LFA-1 mediated HuR translocation and
subsequent mRNA stabilization.
An obvious question stems from our data. What is the signal or signals
that mediate p38 MAPK activation-induced HuR translocation? One candidate
protein is p38 MAPK-activated protein kinase 2 (MK2). MK2 is a molecule that
resides in the cytoplasm and, upon activation by p38 MAPK, binds to its
chaperone, heat shock protein 27 (hsp-27), and translocates to the nucleus (36).
Transfection of cells with a constitutively active MK2 construct induced
stabilization of cytokine transcripts containing AREs (IL-6 and IL-8), while a
dominant negative MK2 construct interfered with p38 MAPK-mediated mRNA
stabilization (37). Recent work calls into question whether p38/MK2 operates in
series or in parallel with HuR. With an elegant series of experiments, they have
identified two distinct domains within the ARE of IL-8, both of which are
necessary for mRNA destabilization in a quiescent cell.

HuR and MK2 bind

separately to each domain. HuR binds to an auxiliary domain within the IL-8
ARE which causes modest mRNA stabilization. HuR binding to the auxiliary
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domain, however, increases the affinity of MK2 binding to the core domain of the
IL-8 ARE. MK2 binding to the core domain leads to further mRNA stabilization
by inhibiting deadenylation of the 3’ tail of the IL-8 transcript (38). These data
suggest that MK2 and HuR operate in parallel and not in series as we propose.
This does not necessarily contradict our model. Firstly, the study only examines
IL-8’s transcript. While the same mechanism may apply to IFN-γ, it has not yet
been confirmed.

Secondly, we only examine HuR translocation after

manipulating MKK3. While we conclude from this data that MKK3 is required for
HuR translocation, and therefore infer that it acts via its substrate, p38 MAPK, we
also established that either MKK3 or a signaling protein proximal to MKK3 must
activate a protein in addition to p38 MAPK to achieve HuR translocation. It is
conceivable that the other protein (or proteins) activated by MKK3 are
responsible for HuR translocation, and that the coordinated action of HuR and
p38/MK2 are required for mRNA stabilization.
The next step beyond discovering the pathway transducing LFA-1
engagement-mediated mRNA stabilization is defining the significance of this
mRNA stabilization to proper immune function in vivo. T cells in general, and T
cell

LFA-1

activation

specifically,

have

been

implicated

in

numerous

immune/inflammatory diseases. The role of LFA-1 in rheumatoid arthiritis has
been known for some time (39). The inflammatory infiltrate within the synovium
of joints in patients suffering from rheumatoid arthritis is rich with T cells, and it
has been shown that LFA-1 engagement by endothelial ligands plays an integral
role in development of the infiltrate.

Whether LFA-1 engagement mediates
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proinflammatory signaling responsible for the development of rheumatoid arthritis
through mRNA stabilization has not been investigated.
Within the context of vascular biology, T cells play a vital role in vascular
pathology such as atherosclerosis, chronic vascular rejection, and angioplasty
restenosis. Among the characteristics shared by the various forms of vascular
pathology is endothelial dysfunction and injury. This endothelial injury leads to
alterations in the endothelial cell’s gene expression profile, including the upregulation of cell adhesion molecules used for leukocyte adhesion. In a study
examining atherosclerotic plaques, the intimal neovasculature within the plaque
displayed significantly elevated levels of E-selectin, ICAM-1, and VCAM-1
expression when compared to normal arterial luminal endothelium.

The

increased expression of these adhesion molecules was strongly associated with
intimal accumulation of leukocytes, particularly T cells (40).

Chronic graft

rejection has also been established as primarily a vascular phenomenon
mediated by T cell invasion into the vasculature, causing dense intimal fibrosis
that is not unlike the mechanism of post-injury restenosis. Furthermore, inhibition
of the CD28 and CD40 signaling pathways within T cells has shown great
promise in attenuating chronic graft rejection in rodents (41).

Percutaneous

transluminal coronary angioplasty (PTCA) has been shown to increase the
concentration of CD4+, IFN-γ expressing T cells. This increase in T cell density
can be attenuated by treating patients with statins following PTCA, which have
been shown to interfere with T cell signaling (42).

Taken together, these data

suggest that atherosclerosis, chronic graft rejection, and angioplasty restenosis
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are all forms of vascular pathology that share the mechanism of T cell adhesion
to injured vascular endothelium, followed by subintimal invasion with subsequent
neointimal proliferation and fibrosis.
The T cell integrin LFA-1 has been implicated in T cell adhesion to
endothelium and the subsequent development of atherosclerosis (43). In fact,
oxidized low density lipoprotein (LDL), long known to be an important contributing
factor for atherosclerosis, has been shown to be a potent trigger for LFA-1
activation

and

subsequent

leukocyte

adhesion

and

transmigration

into

atherosclerotic plaques (44). Angioplasty restenosis shares many mechanisms
of pathogenesis with atherosclerosis. PTCA with additional stent implantation is
associated with a local recruitment of LFA-1 positive lymphocytes to the site of
the procedure (45). Furthermore, studies in Germany show that assessing the
expression of LFA-1, and the monocyte counterpart Mac-1, in patients prior to
angioplasty may predict the subsequent development of angioplasty restenosis
(46).
While T cells, acting through LFA-1 engagement by endothelial ICAM-1,
have been implicated in vascular pathology, the role of signaling events
downstream of LFA-1 engagement in vascular pathology have not been
examined. We aim to determine whether LFA-1 mediated mRNA stabilization of
pro-inflammatory cytokine transcripts is an important step in the development of
vascular pathology. Preliminary data suggest that MKK3 deficient mice reject
HY-mismatched skin grafts over a longer time course than their wild type
counterparts (Figure 14). An HY-mismatch model refers to a syngeneic skin graft
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taken from a male donor and grafted onto a female recipient. A protein encoded
on the Y chromosome of the male donor graft (the HY protein) generates a minor
histocompatability mismatch within the female recipient, causing a chronic graft
rejection (47), but not one that requires immunosupression for graft viability. In
our preliminary experiments, the MKK3 knockout mice take an average of 7 days
longer to reject HY-mismatched skin grafts than wild type BL/6 mice (data not
shown as statistical significance was not reached).

We also have the HY-

mismatch model in place for aorta allograft experiments. In both wild type and
MKK3 knockout mice populations, sections of thoracic aorta are taken from a
male donor and grafted onto a female recipient abdominal aorta. Again, the
donor HY antigen induces a recipient T cell response and chronic graft rejection.
Because the graft is vascular, rejection will more closely approximate vascular
pathology than skin graft rejection.
It is important to note that MKK3 gene deleted mice are deficient in IL-12
production.

IL-12 is a heterodimeric cytokine that plays an integral role in

differentiating naïve CD4+ T cells into Th1 cells by inducing IFN-γ production
(28). The deficiency in IL-12 production in MKK3 knockout mice does not affect
our presented in vitro results since our experiments focus on naïve T cells or T
cell lines and therefore do not require IL-12.

The IL-12 defect is important,

however, in discussing the extension of these experiments to an in vivo system,
particularly when using a graft rejection model.
primarily a T cell-mediated phenomenon.

As stated, graft rejection is

Specifically, a cell-mediated, Th1

phenotype for CD4+ T cells is perhaps the most important component for
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vascular rejection (1).

Without IL-12 production capabilities, MKK3 deficient

naïve T cells are not capable of differentiating into a Th1 phenotype. Therefore,
it would be impossible to determine whether delayed graft rejection was truly a
result of impaired mRNA stabilization of pro-inflammatory cytokine transcripts
upon naïve T cell integrin engagement, or whether the delayed rejection is a
result of the mouse’s inability to generate Th1 cells.
As a solution, our lab is in the process of generating a conditional, “floxed”
HuR knockout mouse.

When crossing the HuR-floxed mouse with a T cell-

specific (lck-promoter) cre recombinase transgenic mouse, a T cell HuR
knockout mouse will be generated. If the mouse has a normal repertoire of T
cells, we will be able to identify the role of HuR in some of the T cell, in vivo
models. Knocking out T cell HuR would not only more definitively show that HuR
is responsible for integrin engagement-mediated mRNA stabilization, it would
allow us to further define the nature of HuR’s association with relevant mRNAs.
These recombinant tools of genetic manipulation would give us the power to
more precisely interrogate the role of HuR in T cell integrin engagementmediated mRNA stabilization, as well as the effects of this mRNA stabilization
upon vascular rejection and other forms of vascular pathology.

37
References
1.

Janeway, C.A., Travers, P., Walport, M., and Shlomchik, M.J. 2001.
Immunobiology: The Immune System in Health and Disease. New
York: Garland Publishing. 732 pp.

2.

Germain, R.N.
MHC-dependent antigen processing and peptide
presentation: providing ligands for T lymphocyte activation. Cell. 1994.
76: 369-397.

3.

Rossetti, G., Collinge, M., Bender, J.R., Molteni, R., and Pardi, R.
Integrin-dependent regulation of gene expression in leukocytes.
Immunol. Rev. 2002. 186: 189-207.

4.

Muller, W.A. and Randolph, G.J. Migration of leukocytes across
endothelium and beyond: molecules involved in the transmigration and
fate of monocytes. J. Leukoc. Biol. 1999. 66: 698-704.

5.

Revilla, C., Gonzalez, A.L., Conde, C., Lopez-Hoyos, M., and Merino, J.
Treatment with anti-LFA-1 alpha monoclonal antibody selectively
interferes with the maturation of CD4-CD8+ thymocytes. Immunology.
1997. 90: 550-556.

6.

Geginat, J., Gossi, G., Bender, J.R., and Pardi, R. Anchorage
dependence of mitogen-induced G1 to S transition in primary T
lymphocytes. J. Immunol. 1999. 162: 5085-5093.

7.

Salomon, B. and Bluestone, J.A. LFA-1 interaction with ICAM-1 and
ICAM-2 regulates Th2 cytokine production. J. Immunol. 1998. 161:
5138-5142.

8.

Smits, H.H., de Jong, E.C., Schuitemaker J.H., Geijtenbeek T.B., van
Kooyk Y., Kapsenberg M.L., and Wierenga E.A. Intercellular adhesion
molecule-1/LFA-1 ligation favors human Th1 development. J. Immunol.
2002. 168: 1710-1716.

9.

Wang, G.J., Collinge, M., Blasi, F., Pardi, R., and Bender, J.R.
Posttranscriptional regulation of urokinase plasminogen activator
receptor messenger RNA levels by leukocyte integrin engagement.
Proc. Natl. Acad. Sci. USA. 1998. 95: 6296-6301.

10.

Umlauf, S.W., Beverly, B., Lantz, O., and Schwartz, R.H. Regulation of
interleukin 2 gene expression by CD28 co-stimulation in mouse T cell
clones: both nuclear and cytoplasmic RNAs are regulated with complex
kinetics. Mol. Cell. Biol. 1995. 15: 3197-3205.

38

11.

Ronald, J.A., Ionescu, C.V., Rogers, K.A., and Sandig, M. Differential
regulation of transendothelial migration of THP-1 cells by ICAM-1/LFA-1
and VCAM-1/VLA-4. J. Leukoc. Biol. 2001. 70: 601-609.

12.

Romanic, A.M. and Madri, J.A. The induction of 72-kD gelatinase in T
cells upon adhesion to endothelial cells is VCAM-1 dependent. J. Cell.
Biol. 1994. 125: 1165-1178.

13.

Bianchi, E., Ferrero, E., Fazioli, F., Mangili, F., Wang, J., Bender, J.R.,
Blasi, F., and Pardi, R. Integrin-dependent induction of functional
urokinase receptors in primary T lymphocytes. J. Clin. Invest. 1996.
98: 1133-1141.

14.

Wang, W., Caldwell, M.C., Lin, S., Furneaux, H., and Gorospe, M. HuR
regulates cyclin A and cyclin B1 mRNA stability during cell proliferation.
EMBO J., 2000. 19: 2340-50.

15.

Peng S.S., Chen, C.Y., Xu N., and Shyu A.B. RNA stabilization by the
AU-rich element binding protein, HuR, an ELAV protein. EMBO J.
1998. 17: 3461-70.

16.

Dean, J.L., Wait, R., Mahtani, K.R., Sully, G., Clark, A.R., and
Saklatvala, J. The 3' untranslated region of tumor necrosis factor alpha
mRNA is a target of the mRNA-stabilizing factor HuR. Mol. Cell. Biol.
2001. 21: 721-30.

17.

Tran H., Maurer, F., and Nagamine Y., Stabilization of urokinase and
urokinase receptor mRNAs by HuR is linked to its cytoplasmic
accumulation induced by activated mitogen-activated protein kinaseactivated protein kinase 2. Mol. Cell. Biol. 2003. 23: 7177-88.

18.

Wang, J.G., Collinge, M., Ramgolam, V., Ayalon, O., Fan, X.C., Pardi,
R., and Bender, J.R. LFA-1-dependent HuR nuclear export and
cytokine mRNA stabilization in T Cell activation. J. Immunol. 2006.
176: 2105-2113.

19.

Robinson, M.J., and Cobb, M.H. Mitogen-activated protein kinase
pathways. Curr. Opin. Cell. Biol. 1997. 2: 180-186.

20.

Tanaka, N., Kamanaka, M., Enslen, H., Dong, C., Wysk, M., Davis,
R.J., and Flavell, R.A. Differential involvement of p38 mitogen-activated
protein kinase kinases MKK3 and MKK6 in T-cell apoptosis. EMBO
Rep. 2002. 3: 785-791.

39
21.

Rincón, M., Enslen, H., Raingeaud, J., Recht, M., Zapton, Y., Su., M.SS., Penix, L.A., Davis, R.J., and Flavell, R.A. Interferon-γ expression by
Th1 effector T cells mediated by the p38 MAP kinase signaling
pathway. EMBO J. 1998. 17: 2817-2829.

22.

Yang, D.D., Conze, D., Whitmarsh, A.J., Barrett, T., Davis, R.J., Rincón,
M., and Flavell, R.A. Differentiation of CD4+ T cells to Th1 cells
requires MAP Kinase JNK2. Immunity. 1998. 9: 575-585.

23.

Dong, C., Yang, D.D., Wysk, M., Whitmarsh, A.J., Davis, R.J., and
Flavell, R.A. Defective T cell differentiation in the absence of JNK1.
Science. 1998. 282: 2092-2095.

24.

Brook, M., Sully, G., Clark, A.R., and Saklatvala, J. Regulation of
tumour necrosis factor alpha mRNA stability by the mitogen-activated
protein kinase p38 signalling cascade. FEBS Letters, 2000. 483: 57-61.

25.

Winzen, R., Gowrishankar, G., Bollig, F., Redich, N., Resch, K., and
Holtmann, H. Distinct Domains of AU-Rich Elements Exert Different
Functions in mRNA Destabilization and Stabilization by p38 MitogenActivated Protein Kinase or HuR. Mol. Cell. Biol. 2004. 11: 4835–4847.

26.

Han, Q., Leng, J., Bian, D., Mahanivong, C., Carpenter, K.A., Pan, Z.K.,
and Huang, S.
Rac1-MKK3-p38-MAPKAPK2 Pathway Promotes
Urokinase Plasminogen Activator mRNA Stability in Invasive Breast
Cancer Cells. J. Biol. Chem. 2002. 277: 48379–48385.

27.

Derijard, B., Raingeaud, J., Barrett, T, Wu, I.H., Han, J., Ulevitch, R.J.,
and Davis, R.J. Independent human MAP-kinase signal transduction
pathways defined by MEK and MKK isoforms. Science. 1995. 267:
682-5.

28.

Lu, H.T., Yang, D.D., Wysk, M., Gatti, E., Mellman, I, Davis, R.J., and
Flavell, R.A. Defective IL-12 production in mitogen-activated protein
(MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 1999. 18:
1845–1857.

29.

Yui, K., Komori, S., Katsumata, M., Siegel, R.M., and Greene M.I..,
Self-reactive T cells can escape clonal deletion in T-cell receptor V beta
8.1 transgenic mice. Proc. Natl. Acad. Sci. U S A. 1990. 87: 71357139.

30.

Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and
Tuschl, T. Duplexes of 21 -nucleotide RNAs mediate RNA interference
in cultured mammalian cells. Nature. 2001. 411: 494-498.

40
31.

Bennett, B.L., Sasaki, D.T., Murray, B.W., O’Leary, E.C., Sakata, S.T.,
Xu, W., Leisten, J.C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S.S.,
Manning, A.M., and Anderson, D.W. SP600125, an anthrapyrazolone
inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA. 2001.
98: 13681-13686.

32.

Tong, L., Pav, S., White, D.M., Rogers, S., Crane, K.M., Cywin, C.L.,
Brown, M.L., and Pargellis, C.A. A highly specific inhibitor of human
p38 MAP kinase binds in the ATP pocket. Nat. Struct. Biol. 1997. 4:
311-6.

33.

Porter J.C., Bracke M., Smith A., Davies D., and Hogg N. Signaling
through integrin LFA-1 leads to filamentous actin polymerization and
remodeling, resulting in enhanced T cell adhesion. J Immunol. 2002
168: 6330-5.

34.

Bohmer, R.M., Scharf, E., and Assoian, R.K. Cytoskeletal integrity is
required throughout the mitogen stimulation phase of the cell cycle and
mediates the anchorage-dependent expression of cyclin D1. Mol. Biol
Cell. 1996. 7: 101-111.

35.

Riteau B., Barber D.F., and Long E.O. Vav1 phosphorylation is induced
by beta2 integrin engagement on natural killer cells upstream of actin
cytoskeleton and lipid raft reorganization. J Exp Med. 2003. 198:46974.

36.

Rouse, J., Cohen, P., Trigon, S., Morange, M., Alonso-Llamazares, A.,
Zamanillo, D., Hunt, T., and Nebreda, A.R. A novel kinase cascade
triggered by stress and heat shock that stimulates MAPKAP kinase-2
and phosphorylation of the small heat shock proteins. Cell. 1994. 78:
1027-37.

37.

Winzen, R., Kracht, M., Ritter, Birgit, Wilhelm, A., Chen, C-Y.A., Shyu,
A-B., Müller, M., Gaestel, M., Resch, K., and Holtmann, H. The p38
MAP kinase pathway signals for cytokine-induced mRNA stabilization
via MAP kinase-activated protein kinase 2 and an AU-rich regiontargeted mechanism. EMBO J. 1999. 18: 4969-4980.

38.

Winzen, R., Gowrishankar, G., Bollig, F., Redich, N., Resch, K., and
Holtmann, H. Distinct domains of AU-rich elements exert different
functions in mRNA destabilization and stabilization by p38 mitogenactivated protein kinase or HuR. Mol. Cell. Biol. 2004. 24: 4835-4847.

39.

Oppenheimer-Marks, N., Brezinschek, R.I., Mohamadzadeh, M., Vita,
R., and Lipsky, P.E. Interleukin 15 is produced by endothelial cells and
increases the transendothelial migration of T cells in vitro and in the

41
SCID mouse-human rheumatoid arthritis model in vivo. J. Clin. Invest.
1998. 101:1261-1272.
40.

O'Brien, K.D., McDonald, T.O., Chait, A., Allen, M.D., and Alpers, C.E.
Neovascular expression of E-selectin, intercellular adhesion molecule1, and vascular cell adhesion molecule-1 in human atherosclerosis and
their relation to intimal leukocyte content. Circulation. 1996. 93:672682.

41.

Sayegh, M.H. and Turka, L.A. The Role of T-Cell Costimulatory
Activation Pathways in Transplant Rejection. NEJM. 1998. 338:18131821.

42.

Tanaka, T., Soejima, H., Hirai, N., Sakamoto, T., Yoshimura, M.,
Kajiwara, I., Miyao, Y., Fujimoto, K., Miyagi, H., Irie, A., Nishimura, Y.,
and Ogawa, H. Comparison of frequency of interferon-γ–positive CD4+
t cells before and after percutaneous coronary intervention and the
effect of statin therapy in patients with stable angina pectoris. Am. J.
Cardiol. 2004. 93: 1547-1549.

43.

Schramm, R., Menger, M.D., Schaefers, H.J., and Thorlacius, H.
Leukocyte adhesion in aorta and femoral artery in vivo is mediated by
LFA-1. Inflamm. Res. 2004. 53: 523-527.

44.

Mine, S., Tabata, T., Wada, Y., Fujisaki, T., Iida, T., Noguchi, N., Niki,
E., Kodama, T., and Tanaka, Y. Oxidized low density lipoproteininduced LFA-1-dependent adhesion and transendothelial migration of
monocytes via the protein kinase C pathway. Atherosclerosis. 2002.
160: 281-288.

45.

Paroli, M., Nigri, A., Pizzuto, F., Benvenuto, R., Gurgo, A., Sardella, G.,
Fravolini, F., Berni, A., and Villatico-Campbell, S. Local recruitment of
LFA-1+ lymphocytes after coronary stent implantation. Am. J. Cardiol.
2001. 87: 1295-1298.

46.

Rahimi, K., Maerz, H.K., Zotz, R.J., and Tarnok, A. Pre-procedural
expression of Mac-1 and LFA-1 on leukocytes for prediction of late
restenosis and their possible correlation with advanced coronary artery
disease. Cytometry B. Clin. Cytom. 2003. 53: 63-69.

47.

Millrain, M., Scott, D., Addey, C., Dewchand, H., Ellis, P., Ehrmann, I.,
Mitchell, M., Burgoyne, P., Simpson, E., and Dyson, J. Identification of
the Immunodominant HY H2-Dk Epitope and Evaluation of the Role of
Direct and Indirect Antigen Presentation in HY Responses. J. Immunol.
2005. 175:7209-7217.

42
48.

Ezekowitz, R.A.B. and Hoffman, J. Innate Immunity.
Immunol. 1998. 10: 9-53.

49.

Rajewsky, K. Clonal selection and learning in the antibody system.
Nature. 1996. 381: 751-758.

50.

Henkart, P.A. Lymphocyte-mediated cytotoxicology: two pathways and
multiple effector molecules. Immunity. 1994. 1: 343-346.

51.

Rincón, M., Flavell, R.A., and Davis, R.A. The JNK and p38 MAP
kinase signaling pathways in T cell-mediated immune responses. Free
Radical Bio. Med. 2000. 28: 1328-1337.

52.

Butcher, E.C., Williams, M., Youngman, K., Rott, L., and Briskin, M.
Lymphocyte trafficking and regional immunity. Adv. Immunol. 1999.
72: 209-253.

53.

Welder, C.A., Lee, D.H., and Takei, F., Inhibition of cell adhesion by
microspheres coated with recombinant soluble intercellular adhesion
molecule-1. J. Immunol. 1993. 150: 2203-10.

54.

Takei, F. Inhibition of mixed lymphocyte response by a rat monoclonal
antibody to a novel murine lymphocyte activation antigen (MALA-2). J.
Immunol. 1985. 134: 1403-7.

55.

Shamri, R., Grabovsky, V., Gauguet, J.M., Feigelson, S., Manevich, E.,
Kolanus, W., Robinson, M.K., Staunton, D.E., von Andrian, U.H., and
Alon, R. Lymphocyte arrest requires instantaneous induction of an
extended LFA-1 conformation mediated by endothelium-bound
chemokines. Nat. Immunol. 2005. 6: 497-506.

Curr. Opin.

Figure 1: The effect of purification on T cell concentration of murine
splenocytes. Murine splenocytes were isolated and purified as described in the
Methods section. A sample of splenocytes was taken after purification. The
samples were analyzed by flow cytometry using an antibody against the T cellspecific protein CD3 conjugated to the fluorescent marker FITC, as well as an
antibody against the NK cell-specific protein NK1.1 conjugated to the fluorescent
marker PE.
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Figure 2: The effect of LFA-1 engagement on IFN-γ mRNA stabilization in
murine T cells.

Mouse splenic T-cells were isolated as described, then

immunostimulated with either PMA or PMA plus ICAM for 3 hr, after which the
transcriptional inhibitor DRB was added (time 0). The RNA was harvested at
time 0 as well as at the indicated times for quantitative, real time RT-PCR using
probes complementary to IFN-γ.

In this and all future mRNA stabilization

experiments, IFN-γ mRNA levels were normalized against the stable transcript
cyclophilin at each time point.
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Figure 3: The effect of LFA-1 engagement on HuR nuclear-to-cytoplasmic
translocation in murine T cells. T cells were isolated from C57BL/6 mouse
spleens and resuspended in LFA-1 activation buffer (2 mM MnCl2), following
which they were plated on coverslips coated with 2.5 µg/ml murine Intercellular
Adhesion Molecule-1 (ICAM-1) or poly-L-lysine for 15, 30, 45 and 60 minutes.
Immunofluorescent analysis was performed with anti-HuR mAb (red) and the
nuclear marker DAPI (blue). Magnification 100X.
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Figure 4: The effect of HuR knockdown on Rac-1-mediated mRNA
stabilization of ARE-containing transcripts in immortalized human T cells.
Jurkat T cells were transfected with a rabbit β-globin construct containing the 3’UTR of uPAR, as well as chloramphenicol acetyl transferase to normalize
transfection levels. The T cells were also transfected with a constitutively active
Rac-1 construct (Rac1 V12, Panel A), or a constitutively active Rac-2 construct
(Rac2 L61, Panel B). The cells were then split into two populations, with half
receiving a double-stranded RNA interference sequence specific for HuR
(HuRsiRNA) while the other half received a scrambled double stranded RNA
sequence (ScRNA). RNA interference succeeded in knocking HuR down by at
least 80% compared to baseline levels (top panels).

AUF-1 was used to

normalize protein levels. The lower panels show the effect of knocking down
HuR on Rac-1-mediated mRNA stabilization. The T cells were stimulated by the
addition of serum and, following the withdrawal of serum, were lysed at various
time points and mRNA levels analyzed at each time point using quantitative, real
time RT-PCR using probes for rabbit β-globin.
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Figure 5: The effect of LFA-1 engagement upon p38 MAPK and JNK
activation in murine T cells.

Murine T cells were suspended in LFA-1

activation buffer and plated on msICAM-1 coated dishes.

Adherent and

nonadherent cells were collected and lysed at the noted time points. The cell
lysates were assayed for total and phosphorylated protein by Western blot
analysis. Panel A shows p38 MAPK activity following LFA-1 engagement by
msICAM-1. Phosphorylated p38 MAPK was normalized to total p38 MAPK within
the Western blot. Panel B shows JNK activity. C-jun is a substrate for JNK, and
phosphorylated c-jun is the customary readout for JNK activity, which was
normalized against total JNK within the Western blot.
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Figure 6: The effect of JNK activity upon LFA-1 engagement-mediated
mRNA stabilization in murine T cells.

Panel A illustrates a sample dose

response curve for SP600125, a JNK-specific pharmacologic inhibitor. Murine T
cells were suspended in LFA-1 activation buffer and plated on msICAM-1 coated
dishes with varying concentrations of SP600125. Adherent and nonadherent
cells were collected and lysed at the noted time points.

JNK activity was

quantitated by normalizing phospho-c-jun against total JNK by Western blot
analysis. Panels B & C: Murine T cells were stimulated for 3 hours with PMA,
PMA and ICAM-1 or PMA, ICAM-1 and SP600125.

Panel B: immediately

following stimulation, the cells were lysed and their mRNA quantitated via
quantitative, real time RT-PCR using primers for IFN-γ. Panel C: Transcription
was inhibited following stimulation.

RNA was harvested at the time of

transcriptional arrest as well as the indicated time points and the mRNA
quantitated via quantitative, real time RT-PCR using primers for IFN-γ.
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Figure 7: Effect of JNK inhibition on LFA-1 engagement-mediated HuR
translocation in murine T cells. T cells were isolated from C57BL/6 mouse
spleens, resuspended in LFA-1 activation buffer containing vehicle or the two
noted doses of SP600125, and plated on coverslips coated with murine ICAM-1
or poly-L-lysine for 60 minutes. Immunofluorescent analysis was performed with
anti-HuR mAb (red) and the nuclear marker DAPI (blue). Magnification 100X.
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Figure 8: The effect of p38 MAPK activity on mRNA stabilization in murine T
cells. Panel A illustrates a sample dose response curve for SB203580, a p38
MAPK-specific pharmacologic inhibitor. Murine T cells were suspended in LFA-1
activation buffer and plated on msICAM-1 coated dishes with varying
concentrations of SB203580. Adherent and nonadherent cells were collected
and lysed at the noted time points.

P38 MAPK activity was quantitated by

normalizing phospho-p38 MAPK against total p38 MAPK by Western blot
analysis. Panels B & C: Murine T cells were stimulated with PMA, PMA and
ICAM-1 or PMA, ICAM-1 and SB203580.

Panel B: immediately following

stimulation, the cells were lysed and their mRNA quantitated via quantitative, real
time RT-PCR using primers for IFN-γ.

Panel C: Transcription was inhibited

following stimulation. RNA was harvested at the time of transcriptional arrest as
well as the indicated time points and the mRNA quantitated via quantitative, real
time RT-PCR using primers for IFN-γ.
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Figure 9: The effect of MKK3 gene deletion upon p38 MAPK and JNK
expression in murine T cells. Murine splenic T cells were suspended in LFA-1
activation buffer and plated on msICAM-1 coated dishes.

Adherent and

nonadherent cells were collected and lysed after 1 hour. p38 MAPK activity (A)
and JNK activity (B) were assessed via Western blot analysis.

Activity was

measured as a function of the phosphorylated enzyme (A) or its substrate (B)
normalized against the total concentration of the MAPK. Data are presented as
the mean value ± SEM (n=3).
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Figure 10: The effect of MKK3 gene deletion upon interferon gamma mRNA
levels in murine T cells. Murine splenic T cells were isolated from MKK3+/+,
MKK3+/-, and MKK3-/- mice and stimulated with PMA and ICAM for 3 hours.
After stimulation, the T cells were lysed and IFN-g mRNA levels were quantitated
via quantitative, real time RT-PCR using primers complementary for IFN-γ. IFN-γ
mRNA levels were normalized against IFN-γ mRNA levels in MKK3+/+ T cells
stimulated with PMA alone. Data are presented as the mean value ± SEM (n=3).
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Figure 11: The effect of MKK3 gene deletion upon LFA-1 engagementmediated mRNA stabilization of interferon gamma transcripts in murine T
cells. Murine splenic T cells were isolated from MKK3+/+, MKK3+/-, and MKK3/- mouse splenocytes and stimulated with PMA and ICAM for 3 hours. After
stimulation, transcription was inhibited by the addition of DRB.

At the time of

transcriptional arrest as well as the indicated time points after addition of DRB, T
cells were lysed, mRNA harvested, and IFN-γ levels analyzed via quantitative,
real time RT-PCR. Data are presented as the mean value ± SEM (n=3).
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Figure 12: The effect of MKK3 gene deletion upon HuR nuclear-tocytoplasmic translocation in murine T cells.

T cells were isolated from

MKK3+/+, MKK3+/-, and MKK3-/- mouse spleens. The cells were then treated
with LFA-1 activation buffer and plated on ICAM-1 coated coverslips for 60
minutes. Immunofluorescent analysis was performed with anti-HuR mAb (red)
and the nuclear marker DAPI (blue). Magnification 100X.
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Figure 13: Proposed LFA-1 signal transduction pathway.
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Figure 14: The effect of MKK3 gene deletion upon rejection of skin grafts in
mice.

Preliminary pictures of skin grafts taken from wild type and MKK3-/-

C57BL/6 male donors and grafted onto wild type and MKK3-/- C57BL/6 female
recipients, respectively. The pictures are taken at 14 and 28 days after graft
transplant. Rejection of the graft causes contraction of the transplanted skin.
Therefore, a larger area of transplanted tissue indicates a greater amount of
viable graft remaining on the recipient. We define rejection at 100% contraction
of the graft (when the recipient’s skin has completely grown over the graft site,
such as MKK3+/+ at 28 days).
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